Inventor · disambiguated record
Amruta Pise
Also filed as: PISE AMRUTA
5 granted patents·2 pending applications·4 citations·filing 2020–2023
70Inventor score
Files withINCELLDX INC7
Top patents by PatentIndex Score
7 records- 0188US11180491B2Method of treating COVID-19 by administering the CCR5/CCL5 (RANTES) interaction inhibitor maravirocINCELLDX INC·Filed 2020·Granted Nov 23, 2021·2 cites·3 claims
- 0286US12228580B2Methods of assigning a COVID pathological type based on a cytokine/chemokine panelINCELLDX INC·Filed 2022·Granted Feb 18, 2025·1 cites·13 claims
- 0383US11402391B2Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonistINCELLDX INC·Filed 2021·Granted Aug 2, 2022·1 cites·18 claims
- 0470US11952373B2Method of treating hypercytokinemia by administering the CCR5/CCL5 (RANTES) interaction inhibitor maravirocINCELLDX INC·Filed 2021·Granted Apr 9, 2024·0 cites·14 claims
- 0566US11629196B2Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactionsINCELLDX INC·Filed 2020·Granted Apr 18, 2023·0 cites·12 claims
- 0659US2024019447A1Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19INCELLDX INC·Filed 2023·Application pending·0 cites
- 0758US2025099444A1Methods of Treating a Subject for Long-Haul COVID-19, and Compositions for Use in the SameINCELLDX INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amruta Pise files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →